Oracle stock gains amid ETF inflows and weak momentum signals

Oracle stock gains amid ETF inflows and weak momentum signals
Oracle jumps 3.07% to $119.66 today

Oracle (ORCL) stock is trading at $119.66, up 3.07% on the day. The price sits above short-term moving averages but remains below key medium- and long-term averages.

ORCL price prediction
24H 0.05%
$119.31
48H -0.76%
$118.34
7D -1.38%
$117.61
1M -6.2%
$111.86
3M -28.86%
$84.83
6M -47.19%
$62.97
12M -49.84%
$59.82
Current price: $119.25 -6.1450 4.90%
Closed 11/16
Daily range 118.27 Arrow from to Icon 122.56
Weekly range 115.59 Arrow from to Icon 130.76
Loading...

Highlights

  • Oracle abandoned a $7 billion chip deal with Tencent due to escalating U.S.–China technology tensions.
  • Oracle reported trailing-12-month revenue of $71.78 billion, up 19.2% year-over-year, and saw $111.1 million in ETF inflows.
  • Shares of Oracle are exhibiting short-term buyer interest but remain under medium- and long-term downside pressure, with an expected trading range of $111.08 to $128.24 in the next few sessions.

Semiconductor risks and ETF inflows shape investor sentiment after chip deal exit

Oracle's decision to abandon a $7 billion chip deal with Tencent due to intensifying U.S.–China technology tensions marks a significant shift in the company's technology strategy, as reported by Yahoo Finance. This move may prompt cautious sentiment among investors given the potential risks to Oracle's access to key semiconductor assets and exposure to global tech supply dynamics. However, the company's strong fundamental backdrop is reflected in its trailing-12-month revenue of $71.78 billion, up 19.2% year-over-year, while ETF inflows totaling $111.1 million, according to Yahoo Finance, add further liquidity and underline institutional demand.

Oracle Corporation asset chart
Oracle Corporation price dynamics. Source: TradingView.

Mixed momentum amid support at Kijun and moving average resistance

ORCL is currently positioned above its MA-20 at $117.85 but trades below the MA-50 at $124.66 and remains well under its long-term MA-200 at $155.38. The Ichimoku Kijun level at $119.53 acts as immediate support. Momentum indicators present a mixed outlook: MACD shows a strong sell and ADX maintains a sell reading, indicating ongoing downside risk, while both RSI and CCI are neutral. The Stochastic RSI is overbought, highlighting potential for short-term pullbacks or consolidation. Bull/Bear Power is mildly positive at 0.39, pointing to some intraday buying pressure despite wider market hesitance. Divergence among oscillators and momentum signals suggests uncertainty in the immediate price action.

Rangebound outlook as downside risk edges over breakout chance

In the short term, ORCL is expected to consolidate within a typical volatility band between $111.08 and $128.24 over the next 2–3 sessions. There is a slightly higher probability (52%) of a move lower, with a 48% chance of an upside breakout. The baseline scenario anticipates the price will remain rangebound, with bullish continuation contingent on a breakout above resistance, while a sustained drop below immediate support could accelerate downside toward the lower end of the projected range.

Viktoras Karapetjanc, analyst at Traders Union, believes Oracle shows impressive fundamental strength despite recent global tech headwinds. He sees robust revenue growth and strong institutional inflows helping to offset caution after the chip deal abandonment. The near-term setup remains mixed, but momentum could turn positive if buyers keep returning. "If key support holds and macro trends stabilize, I see Oracle well positioned for renewed upside in the coming weeks."

Previously it was reported that Oracle’s canceled chip-leasing deal and substantial capital raise had introduced elevated risks and contributed to sustained downside momentum for the stock. The current analysis adds nuance, highlighting a mixed technical outlook and suggesting that traders should monitor $119.53 as an immediate support level for indications of either stabilization or renewed weakness.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.